Galenica has entered into a strategic partnership with Spagyros AG, a manufacturer of alternative medical products, as a shareholder.
Galenica AG operates as a healthcare provider in Switzerland and internationally. It operates through two segments, Health & Beauty, and Services.
Kellerhals Carrard advised Galenica on the transaction with a team composed by Beat Brechbühl (picture) and Cécile Matter.
Involved fees earner: Beat Brechbühl – Kellerhals Carrard; Cécile Matter – Kellerhals Carrard;
Law Firms: Kellerhals Carrard;
Clients: Galenica AG;
